Date Name Title Filing Type Shares Traded Price Total Held
Jan 03, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,277 -- --
Dec 18, 2006
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,921 -- 4,921
Dec 18, 2006
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 195,079 -- 195,079
May 19, 2006
Director, EVP CSO President Regeneron Re
Director, EVP CSO President Regeneron Re Form 4 Bona fide gift 670 -- 62,424
Jan 09, 2006
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Open market or private sale of non-derivative or derivative security 7 $16.87 66,819
Jan 09, 2006
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Open market or private sale of non-derivative or derivative security 9 $16.88 66,810
Jan 09, 2006
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Open market or private sale of non-derivative or derivative security 30 $16.91 66,780
Jan 09, 2006
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Open market or private sale of non-derivative or derivative security 34 $16.92 66,746
Jan 09, 2006
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Open market or private sale of non-derivative or derivative security 30 $16.98 66,716
Jan 09, 2006
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Open market or private sale of non-derivative or derivative security 74 $16.99 66,642

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.